Risk Assessment and Regulation of Plants Modified by Modern Biotechniques: Current Status and Future Challenges

2019 ◽  
Vol 70 (1) ◽  
pp. 699-726 ◽  
Author(s):  
Joachim Schiemann ◽  
Antje Dietz-Pfeilstetter ◽  
Frank Hartung ◽  
Christian Kohl ◽  
Jörg Romeis ◽  
...  

This review describes the current status and future challenges of risk assessment and regulation of plants modified by modern biotechniques, namely genetic engineering and genome editing. It provides a general overview of the biosafety and regulation of genetically modified plants and details different regulatory frameworks with a focus on the European situation. The environmental risk and safety assessment of genetically modified plants is explained, and aspects of toxicological assessments are discussed, especially the controversial debate in Europe on the added scientific value of untargeted animal feeding studies. Because RNA interference (RNAi) is increasingly explored for commercial applications, the risk and safety assessment of RNAi-based genetically modified plants is also elucidated. The production, detection, and identification of genome-edited plants are described. Recent applications of modern biotechniques, namely synthetic biology and gene drives, are discussed, and a short outlook on the future follows.

Author(s):  
Hamza Armghan Noushahi ◽  
Mubashar Hussain

The health of genetically engineered foods/plants, which is one of the significant issues has been raised in recent years. Various non-governmental organizations and customers recommended that all GM foods before authorization for human consumption should be subject to long-term animal feed studies. The fundamental purpose of this review is to assess the new potential harmful impact/safety assessment of genetically engineered plants for the use of humans. A balance in the number of research groups, depending on their research, a variety of GM crops (maize and soybeans in particular) are varied as for traditional non-genetically modified plants. It is worth remembering that most of the experiments were carried out in biotechnology firms that sell these GM plants. In this review, we discussed in detail the risk assessment of genetically modified plants.


Sign in / Sign up

Export Citation Format

Share Document